threonine has been researched along with Lymphoma, B-Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giannakoulas, N; Melachrinou, M; Sirinian, C; Symeonidis, A; Zolota, V | 1 |
| Boyle, P; Brown, HN; Guss, C; Han, X; Hoffman, A; Leaderer, D; Qin, Q; Stevens, RG; Zhang, Y; Zheng, T; Zhu, Y | 1 |
| Cheung, SM; Duronio, V; Ma, K; Marshall, AJ | 1 |
| Sheibani, N; Sorenson, CM | 1 |
4 other study(ies) available for threonine and Lymphoma, B-Cell
| Article | Year |
|---|---|
Overexpression of phosphorylated p27 Kip1 at threonine 187 may predict outcome in aggressive B-cell lymphomas.
Topics: Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Humans; Immunohistochemistry; Lymphoma, B-Cell; Phosphorylation; Predictive Value of Tests; Prognosis; Survival Analysis; Threonine | 2011 |
Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.
Topics: Aged; Alanine; Amino Acid Substitution; Basic Helix-Loop-Helix Transcription Factors; Circadian Rhythm; CLOCK Proteins; Connecticut; Female; Genetic Predisposition to Disease; Genetic Testing; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Molecular Epidemiology; Nerve Tissue Proteins; Polymorphism, Genetic; Population; Risk; Threonine; Trans-Activators | 2007 |
PI(3,4,5)P3 and PI(3,4)P2 levels correlate with PKB/akt phosphorylation at Thr308 and Ser473, respectively; PI(3,4)P2 levels determine PKB activity.
Topics: Antibodies; B-Lymphocytes; Cell Line, Tumor; Cell Membrane; Dose-Response Relationship, Immunologic; Enzyme Activation; Humans; Immunoglobulin Fab Fragments; Inositol Polyphosphate 5-Phosphatases; Kinetics; Ligands; Lymphoma, B-Cell; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; Receptors, Antigen, B-Cell; Receptors, IgG; Recombinant Fusion Proteins; Second Messenger Systems; Serine; Threonine; Transfection | 2008 |
Altered regulation of SHP-2 and PTP 1B tyrosine phosphatases in cystic kidneys from bcl-2 -/- mice.
Topics: Animals; Cell Differentiation; Cytoskeletal Proteins; Epithelial Cells; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Enzymologic; Glutamic Acid; Intracellular Signaling Peptides and Proteins; Kidney Diseases, Cystic; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Mice; Mice, Mutant Strains; Paxillin; Phosphoproteins; Phosphorylation; Pregnancy; Proline; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-bcl-2; Serine; SH2 Domain-Containing Protein Tyrosine Phosphatases; src Homology Domains; Threonine | 2002 |